Wall Street Journal
Orexigen soared 36% to $7.75 in after-hours trading after saying it will inform data at 8 am EDT Monday from three large Phase III clinical trials of its ...
and more »
Welcome to my new trading blog based of after hours stocks. Please subscribe for updates.
No comments:
Post a Comment